Страна: Португалия
Язык: английский
Источник: HMA (Heads of Medicines Agencies)
diclazuril 2.5 mg/ml
LILLY FRANCE
QP51AJ03
Oral suspension
diclazuril
Sheep Young
2011-07-24
1 _ _ SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vecoxan 2.5 mg/ml Oral Suspension for lambs and calves 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: _ACTIVE SUBSTANCE: _ Diclazuril 2.5 mg _ _ _EXCIPIENTS: _ Methyl para hydroxybenzoate (E218) 1.8 mg Propyl para hydroxybenzoate (E216) 0.2 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM White, oral suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Ovine (lambs) and bovine (calves). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In lambs: Prevention of coccidiosis caused by _Eimeria crandallis_ and _Eimeria ovinoidalis_. In calves: Prevention of coccidiosis caused by _Eimeria bovis_ and _Eimeria zuernii_. If there is no recent and confirmed history of clinical coccidiosis, the presence of coccidia in the flock or herd should be confirmed by faecal sampling prior to treatment. 4.3 CONTRAINDICATIONS None known. 2 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES To ensure a correct dosage, body weight should be determined as accurately as possible. Calves: in certain cases, only a transient reduction of oocyst shedding may be achieved. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Shake well before use. The preferred timing of treatment is directed by the known epidemiology of _Eimeria _ _spp._ and the presence of coccidia in the flock or herd should be confirmed by faecal sampling prior to treatment, if there is no recent and confirmed history of clinical coccidiosis. Coccidiosis is an indicator of insufficient hygiene in the flock/pen. It is Прочитать полный документ